FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2015394590> ?p ?o ?g. }

• W2015394590 endingPage "3756" @default.
• W2015394590 startingPage "3746" @default.
• W2015394590 abstract "The objective of the study was to evaluate the efficacy of 5 yr of depot somatostatin analogs (SSAs) as first-line therapy in acromegaly.Primary measures were fasting GH 2.5 microg/liter or less and IGF-I normalized for age and tumor shrinkage. Secondary measures were control of hypertension, arrhythmias, left ventricular hypertrophy, diastolic and systolic dysfunction, and change in lipid and glucose profile.Patients included 45 de novo patients (18 women and 27 men, aged 20-82 yr); 28 were treated with octreotide-long-acting release and 17 with lanreotide.GH was controlled in 100% and IGF-I levels in 97.8%, tumor shrinkage was 74.9 +/- 22.1 and 78.2+/-14.5%, in the octreotide-long-acting release and lanreotide groups, respectively. There was a significant improvement in the prevalence of hypertension (from 46.7 to 22.2%, P = 0.027), arrhythmias (from 17.8% to zero, P = 0.01), left ventricular hypertrophy (from 82.2 to 42.2%, P < 0.0001), diastolic dysfunction (from 60.0 to 15.6%, P < 0.0001), systolic dysfunction (from 40.0 to 4.4%, P < 0.0001), and hypertriglyceridemia (from 40.0 to 4.4%, P < 0.0001). The prevalence of impaired glucose tolerance (IGT; from 28.9 to 20.0%. P = 0.46) and diabetes mellitus (from 22.4 to 31.1%, P = 0.64) did not change.In patients with severe comorbidities and those who refuse surgery, 5 yr of exclusive SSA therapy induce successful control of GH and IGF-I; tumor shrinkage (by median 80%), and improvement of hypertension, cardiac performance; and dyslipidemia. No patient was withdrawn from treatment because of side effects, and glucose tolerance was stable. We suggest that first-line SSA treatment may be safely continued in patients with acromegaly, according to an individual patient's indications and preferences." @default.
• W2015394590 created "2016-06-24" @default.
• W2015394590 creator A5003544129 @default.
• W2015394590 creator A5036471704 @default.
• W2015394590 creator A5055828753 @default.
• W2015394590 creator A5063936702 @default.
• W2015394590 creator A5077499862 @default.
• W2015394590 date "2009-10-01" @default.
• W2015394590 modified "2023-10-13" @default.
• W2015394590 title "Effects of Initial Therapy for Five Years with Somatostatin Analogs for Acromegaly on Growth Hormone and Insulin-Like Growth Factor-I Levels, Tumor Shrinkage, and Cardiovascular Disease: A Prospective Study" @default.
• W2015394590 cites W1983367273 @default.
• W2015394590 cites W1984793434 @default.
• W2015394590 cites W1993733299 @default.
• W2015394590 cites W1994040728 @default.
• W2015394590 cites W1997014156 @default.
• W2015394590 cites W1998538661 @default.
• W2015394590 cites W2001947604 @default.
• W2015394590 cites W2004585879 @default.
• W2015394590 cites W2011106362 @default.
• W2015394590 cites W2028425454 @default.
• W2015394590 cites W2032467001 @default.
• W2015394590 cites W2040054585 @default.
• W2015394590 cites W2040743647 @default.
• W2015394590 cites W2040844989 @default.
• W2015394590 cites W2042559047 @default.
• W2015394590 cites W2071804899 @default.
• W2015394590 cites W2075127147 @default.
• W2015394590 cites W2081324142 @default.
• W2015394590 cites W2081387046 @default.
• W2015394590 cites W2100129802 @default.
• W2015394590 cites W2103019498 @default.
• W2015394590 cites W2103938643 @default.
• W2015394590 cites W2107760944 @default.
• W2015394590 cites W2111216596 @default.
• W2015394590 cites W2118341413 @default.
• W2015394590 cites W2119094244 @default.
• W2015394590 cites W2123416598 @default.
• W2015394590 cites W2128035112 @default.
• W2015394590 cites W2140572454 @default.
• W2015394590 cites W2145336503 @default.
• W2015394590 cites W2156121263 @default.
• W2015394590 cites W2156142359 @default.
• W2015394590 cites W2160234571 @default.
• W2015394590 cites W2160989555 @default.
• W2015394590 cites W2167146922 @default.
• W2015394590 cites W2169614922 @default.
• W2015394590 cites W2171357500 @default.
• W2015394590 cites W2172067681 @default.
• W2015394590 cites W2416968716 @default.
• W2015394590 cites W4250058955 @default.
• W2015394590 cites W4256372163 @default.
• W2015394590 doi "https://doi.org/10.1210/jc.2009-0941" @default.
• W2015394590 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19622615" @default.
• W2015394590 hasPublicationYear "2009" @default.
• W2015394590 type Work @default.
• W2015394590 sameAs 2015394590 @default.
• W2015394590 citedByCount "125" @default.
• W2015394590 countsByYear W20153945902012 @default.
• W2015394590 countsByYear W20153945902013 @default.
• W2015394590 countsByYear W20153945902014 @default.
• W2015394590 countsByYear W20153945902015 @default.
• W2015394590 countsByYear W20153945902016 @default.
• W2015394590 countsByYear W20153945902017 @default.
• W2015394590 countsByYear W20153945902018 @default.
• W2015394590 countsByYear W20153945902019 @default.
• W2015394590 countsByYear W20153945902020 @default.
• W2015394590 countsByYear W20153945902021 @default.
• W2015394590 countsByYear W20153945902022 @default.
• W2015394590 countsByYear W20153945902023 @default.
• W2015394590 crossrefType "journal-article" @default.
• W2015394590 hasAuthorship W2015394590A5003544129 @default.
• W2015394590 hasAuthorship W2015394590A5036471704 @default.
• W2015394590 hasAuthorship W2015394590A5055828753 @default.
• W2015394590 hasAuthorship W2015394590A5063936702 @default.
• W2015394590 hasAuthorship W2015394590A5077499862 @default.
• W2015394590 hasBestOaLocation W20153945901 @default.
• W2015394590 hasConcept C126322002 @default.
• W2015394590 hasConcept C134018914 @default.
• W2015394590 hasConcept C2776002628 @default.
• W2015394590 hasConcept C2776297358 @default.
• W2015394590 hasConcept C2776919658 @default.
• W2015394590 hasConcept C2777391703 @default.
• W2015394590 hasConcept C2777433750 @default.
• W2015394590 hasConcept C2778163477 @default.
• W2015394590 hasConcept C2778913445 @default.
• W2015394590 hasConcept C2779306644 @default.
• W2015394590 hasConcept C2779609023 @default.
• W2015394590 hasConcept C2780609358 @default.
• W2015394590 hasConcept C2781025020 @default.
• W2015394590 hasConcept C2984496839 @default.
• W2015394590 hasConcept C555293320 @default.
• W2015394590 hasConcept C71315377 @default.
• W2015394590 hasConcept C71924100 @default.
• W2015394590 hasConcept C84393581 @default.
• W2015394590 hasConceptScore W2015394590C126322002 @default.
• W2015394590 hasConceptScore W2015394590C134018914 @default.
• W2015394590 hasConceptScore W2015394590C2776002628 @default.
• W2015394590 hasConceptScore W2015394590C2776297358 @default.

• next